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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 















Monkeys that had recovered from infection 
with the new coronavirus were protected from 
re-infection, although how long the protection 
lasts is unclear. 



















 In this study, COVID-19 disease 
outcomes (confirmed cases, deaths 
and recoveries), testing capacities and 
disease management approaches 
among African countries were 
evaluated. 
 Egypt, South Africa, Morocco and 





with highest values of COVID-19 
disease outcomes on the continent 
during the 75-day period of 
observation. 
 The study recommends that the 
approaches adopted by the African 
countries which achieved high 
recovery rates from COVID-19 should 
be integrated into healthcare 
management plans for the disease 












 Under what conditions can individual 
quarantine more effectively control 
COVID-19 than active monitoring? 
 This model highlights the urgent need 
for more data on the serial interval 
and the extent of presymptomatic 
transmission to make data-driven 
policy decisions regarding the cost–
benefit comparisons of individual 
quarantine versus active monitoring of 
contacts. To the extent that these 
interventions can be implemented, 
they can help mitigate the spread of 
SARS-CoV-2. 
        








Is Nigeria really 











Research shows that control measures are 
working but not effective enough to keep 
R(t) below one. Also, the estimated 
fractional reported symptomatic cases are 
between 10 to 50%. Our analysis has shown 
evidence that the existing control measures 
are not enough to end the epidemic and 






A follow-up study 
Plos One/ 
Article 
Work-related transmission is considerable in 
early COVID-19 outbreaks, and the elevated 
risk of infection was not limited to HCW. 
Implementing preventive/surveillance 



















Molecular-dynamics simulations together with 
virtual high-throughput screening provide a 
means of quick evaluation of existing drugs for 
antiviral activity. The authors explain how these 
methods serve in the quest for drugs to treat 
Covid-19. 






20.05.20 COVID-19 in 
Uganda: 
Predicting 












 The results indicate that COVID-19 
impact on Uganda may be relatively 
light, while there is a high risk of a 
significant negative impact on other 
disease burden if the lockdown 
response to COVID-19 is prolonged.  
 The results are likely to extend to other 
sub-Saharan populations, underlining 
the importance of tailoring COVID-19 
responses according to population 
structure and potential disease 
vulnerabilities. 
Comments, Editorials, Opinions, Blogs, News 
20.05.20 Vitamin-D and COVID-19: do deficient 
risk a poorer outcome? 
  
The Lancet Diabetes 
and Endocrinology/ In 
Focus 
Fiona Mitchell 
19.05.20 Septic shock presentation in 
adolescents with COVID-19 












18.05.20 How covid-19 is accelerating the 
threat of antimicrobial resistance 
BMJ/ Opinion Jeremy Hsu 
19.05.20 Coronavirus vaccine trials have 
delivered their first results — but their 
promise is still unclear 
Nature/ News Ewen 
Callaway 
21.05.20 Africa: Let's Prepare for a Marathon 
Struggle Against COVID-19 
  
All Africa Dr Chibuzo 
Okonta 
20.05.20 South Africa: Why Easing the 
Lockdown Threatens to Put Workers 
in South Africa At Risk  
All Africa   
21.05.20 South Africa: SAMRC Scientists 
Harvest Live Coronavirus for 
Validation of Test Kits 
All Africa   
21.05.20 South Sudan: Minister Makuei Tests 
Positive for COVID-19 
All Africa   
21.05.20 Africa: COVID-19 'Is an African 
Governance Crisis' 
All Africa   
20.05.20 Global solidarity with Africa is an 
imperative 
UN brief   
20.05.20 How Academic Health Systems Can 
Move Forward Once COVID-19 
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 This policy brief takes a snapshot of 
immediate impacts of the pandemic 
on health, economies, peace, 
security, human rights and 
humanitarian assistance in Africa. 
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Online learning & events 





WHO Academy and 
WHO Info mobile 
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online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
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About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
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